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OBSERVATIONS
Ten Nights of
Moderate Hypoxia
Improves Insulin
Sensitivity in Obese
Humans
Hypoxia in obese adipose tissue (AT)plays an important role in the de-velopment of whole-body insulin
resistance by inducing local inﬂammation
and the release of proinﬂammatory cyto-
kines (1). Yet, living at high altitude is
associated with a lower prevalence of im-
paired fasting glucose and type 2 diabetes
comparedwith living at lowaltitude (2). Fur-
thermore, exposure to hypoxic environ-
ments increases whole-body glucose ﬂuxes
in healthy males and glucose uptake in hu-
man and murine skeletal muscle (3). In
addition, exercising under hypoxic condi-
tions improves glucose tolerance more
than exercising under normoxia (4),
strongly suggesting an insulin-sensitizing
effect of hypoxia. Therefore, we hypothe-
sized that exposing obese men to 10 con-
secutive nights of moderate hypoxia
(15 6 0.5% O2, ;2,400 m elevation)
would improve insulin sensitivity.
Eight healthy obese men (4 Cauca-
sians, 3 African Americans, and 1 His-
panic of mean 6 SEM age 28 6 1 years,
weight 96.5 6 5.3 kg, and BMI 32.7 6
1.3 kg/m2) without evidence of chronic
disease or sleep apnea and taking no
medication participated in this study.
The protocol was approved by the in-
stitutional review board at Pennington
Biomedical Research Center (Baton Rouge,
LA). Subjects slept for 10 consecutive
nights (;10 h/night, $100 h in total)
in a hypoxic tent (Hypoxico Inc., New
York, NY) maintained at ;15% O2 (range
14.5–15.5%O2,;2,400mabove sea level)
using nitrogen dilution. Biopsies of ab-
dominal subcutaneous AT and skeletal
muscle were obtained at baseline and on
day 11 under normoxic and hypoxic (AT
only) conditions. The oxygen tension in
subcutaneous AT was also measured in
normoxia at baseline and under hyp-
oxia and normoxia on day 11 using dual
temperature-oxygen tension probes (Licox,
Integra LifeSciences, Plainsboro, NJ) as
previously described (5).
In vivo insulin sensitivity was mea-
sured by a two-step hyperinsulinemic-
euglycemic clamp (low insulin, 20
mU/m2/min for 180 min; high insulin,
80 mU/m2/min for 120 min), and the glu-
cose disposal rate (GDR) was calculated.
Substrate oxidation rates and energy ex-
penditure were assessed by indirect calo-
rimetry (Deltatrac II; Datex-Ohmeda) at
the end (30 min) of each stage of the
clamp. In vitro, myotubes obtained from
biopsied muscle were cultured and differ-
entiated for 5 days and then incubated at
37°C under normoxic or hypoxic condi-
tions (15% O2) for 4 h with measures of
glucose uptake (6). Protein and gene ex-
pression were measured in skeletal muscle
using Western immunoblotting and real-
time PCR and adjusted to glyceraldehyde-
3-phosphate dehydrogenase or Ponceau
S stain and to cyclophilin A expression,
respectively.
In response to the 10-night hypoxia
treatment, subjects lost an average of
1.2 6 0.3 kg (P 5 0.003), and AT pO2
tended to decrease from 51.1 6 5.7 to
40.9 6 2.1 mmHg (P 5 0.07). This was
accompanied by a decrease in fasting glu-
cose from 94.86 3.3 mg/dL at baseline to
91.8 6 2.7 mg/dL on day 12 (P 5 0.04)
but unchanged fasting insulin (11.16 2.9
vs. 10.36 2.2mU/L; P5 0.28). At high in-
sulin infusion, GDR increased from 8.3 6
1.8 to 9.2 6 1.6 mg/kg/min (P 5 0.02),
indicating improved whole-body insulin
sensitivity (Fig. 1A). The relative change
in GDR at high insulin was 20 6 8% and
was inversely correlated with baseline
GDR (r 5 20.71, P 5 0.05) but did
not correlate with weight loss (P 5
0.22). GDR was somewhat increased
(23 6 17%) at low insulin infusion
from 2.6 6 0.5 to 3.2 6 0.7 mg/kg/
min (P 5 0.09). Impressively, half of
the subjects experienced at least a 38%
improvement in GDR at either low or
high insulin.
These in vivo improvements in in-
sulin sensitivity were corroborated by in
vitro experiments showing a 626 5% in-
crease (P5 0.0006) in insulin-independent
glucose uptake in primary myotubes ex-
posed to hypoxia (15% O2) for 4 h and
no change in insulin-dependent uptake
(Fig. 1B). In AT, hypoxia-inducible
factor 1a expression tended to be higher
under hypoxia than normoxia either at
baseline or at postintervention (P 5
0.09). Interestingly, muscle expression of
the insulin signaling proteins Akt and
IRS1 and of the mitochondrial complexes
I-V and peroxisome proliferator–activated
receptor g coactivator 1awere unchanged
after the hypoxia treatment. However,
gene expression of peroxisome proliferator–
activated receptor g coactivator 1a and
COL6A3 decreased by 56 6 7% (P 5
0.02) and 48 6 16% (P 5 0.05),
respectively.
In line with studies performed in ro-
dents and isolated human skeletal muscle,
Figure 1—A: 10 nights under moderate hypoxia improves insulin sensitivity, as measured by GDR during a hyperinsulinemic-euglycemic clamp
at low (20 mU/m2/min) and high (80 mU/m2/min) insulin infusion. B: 4 h of hypoxia improves basal but not insulin-stimulated glucose uptake in
cultured human myotubes. *P # 0.05, ‡P # 0.10.
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this study reports for the ﬁrst time a
reduced fasting glucose level and im-
proved whole-body (skeletal muscle) and
hepatic insulin sensitivity after nightly
exposure to moderate hypoxia. Indeed,
controlled studies at altitude and after
acute exposure to hypoxia during exercise
report enhancements in carbohydrate
metabolism, including increased glucose
oxidation, reduced fasting insulin and
glucose, and higher ﬂuxes of glucose (4).
The improvements in GDR at low and high
doses of insulin were on average .20%,
with half of the subjects experiencing a
38% or greater improvement in GDR at
one of the two doses. This was corroborated
by an increase in non–insulin-dependent
glucose uptake in primary myotubes.
Skeletal muscle protein expression and
in vitro experiment data show that insu-
lin signaling remained unaffected, sug-
gesting enhanced insulin-independent
translocation of glucose transporters
by hypoxia (7), such as is encountered
during exercise. Since these remarkable
improvements in whole-body insulin
sensitivity were greatest in those with
the worst baseline insulin sensitivity,
our results suggest that nightly exposure
to moderate hypoxia may provide a new
therapeutic avenue to improve carbohy-
drate metabolism in prediabetes and type
2 diabetes.
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